Atlas Trials

Study Evaluating the Efficacy of Maintenance Olaparib and Cediranib or Olaparib Alone in Ovarian Cancer Patients

Clinical trial NCT03278717 · UNKNOWN

Trial details

NCT number
NCT03278717
Sponsor
University College, London
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2018-06-15
Primary completion
2023-12-01
Enrollment
330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.